top of page
Andypilepsy
Across the world, 50 million people have epilepsy. In France, 70% of them can have an efficient access to medical treatments, but 50% of them abandon them notably because of their side effects (depression, numb, drowsiness, etc.)
After interviews with patients, doctors and pharmaceutical actors, as well as a deep study research in multidisciplinary teamwork, we adapted a solution for patients with diabetes, to decrease by half the side effects of anti-epileptic drugs.
The European market entry can take as little as 5 years.
Client: Brain Institute - Pitié Salpétrière
Year: 2022
bottom of page